Incidence of new-onset diabetes among sudanese renal transplant patients using different immunosuppressive regimens: A retrospective study
Background: New onset diabetes after renal transplant (NODAT) is a serious complication of therapy with immunosuppressive drugs. The aim of this study was to estimate the incidence of NODAT and its association with immunosuppressant regimens within 6 months of the administration. Methodology: A desc...
Guardado en:
Autores principales: | Alaa Mohammedazeem Elzain, Safaa Badi, Bashir Alsiddig Yousef, Habab Khalid Elkheir |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer Medknow Publications
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e4f8520dfd754aa7a43f227f58c87e0f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Post-Transplant Malignancies following Pancreas Transplantation: Incidence and Implications on Long-Term Outcome from a Single-Center Perspective
por: Felix J. Krendl, et al.
Publicado: (2021) -
Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response
por: Florian Terrec, et al.
Publicado: (2021) -
Immunogenetics of new onset diabetes after transplantation in Kuwait
por: Jahromi M, et al.
Publicado: (2019) -
Post-transplantation diabetes mellitus: an overview
por: Igor Alexandrovich Sklyanik, et al.
Publicado: (2015) -
Comparison of COVID-19 outcomes in organ transplant recipients (OTr) and non-transplant patients: a study protocol for rapid review
por: Alexis H. Lerner, et al.
Publicado: (2021)